Tag: Arcus Biosciences Inc.

[breadcrumb_custom]

Technologies

At $18.21 Arcus Biosciences Inc (NYSE: RCUS) Is Worth A Gamble

Arcus Biosciences Inc (NYSE:RCUS)’s traded shares stood at 1.01 million during the last session, with the company’s beta value hitting 0.80. At the close of

Science

A Quick Glance At Arcus Biosciences Inc (NYSE: RCUS) Stock: It Is up 31.77% From Its 52-Week Low; YTD, It Is Down -0.63 Percent

During the last session, Arcus Biosciences Inc (NYSE:RCUS)’s traded shares were 1.64 million, with the beta value of the company hitting 0.81. At the end

Science

Arcus Biosciences Inc (NYSE: RCUS) Could Have Exceptional Returns?

In the last trading session, 1.28 million shares of the Arcus Biosciences Inc (NYSE:RCUS) were traded, and its beta was 0.81. Most recently the company’s

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: Arcus Biosciences Inc.

At $18.21 Arcus Biosciences Inc (NYSE: RCUS) Is Worth A Gamble

A Quick Glance At Arcus Biosciences Inc (NYSE: RCUS) Stock: It Is up 31.77% From Its 52-Week Low; YTD, It Is Down -0.63 Percent

Arcus Biosciences Inc (NYSE: RCUS) Could Have Exceptional Returns?

Categories

Quick links